Literature DB >> 21909756

The patterns and expression of KDR in normal tissues of human internal organs.

Jianfei Huang1, Huijun Zhu, Xudong Wang, Qi Tang, Hua Huang, Kerong Wu, Jin Zhu, Zhenqing Feng, Gongshen Shi.   

Abstract

KDR has been implicated for playing an important role in the formation of new blood vessels and in solid tumor growth. It was considered as one of the most important regulators of angiogenesis and a key target in anticancer treatment. In the present study, we characterized KDR mRNA and protein expression in normal tissues of perinatal and adult tissues using One-step Real-Time RT-PCR and immunohistochemistry with a self-made anti-KDR antibody. The expression of KDR mRNA and protein in perinatal internal organs were all higher than in adult organs including brain, kidney, liver, lung and heart, respectively. KDR protein was presented in the cell plasma membrane of human internal tissues. The expression of KDR protein was raised in macrophage of spleen, and decreased in neurons of brain, myocardium, bronchial epithelial cells and alveolar epithelial cell, proximal and distal tubules cells, and hepatic cells with the maturity process of human organs. Notably, the order of KDR protein expression from highest to lowest is as follows: brain, liver, heart, kidney, and lung in adult tissues with statistically significant. It follows that how to balance the potential therapeutic side effect with human internal organs in targeted therapy of over-expressing KDR tumor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909756     DOI: 10.1007/s10735-011-9355-1

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  40 in total

1.  The significance of VEGF-C/VEGFR-2 interaction in the neovascularization and prognosis of nephroblastoma (Wilms' tumour).

Authors:  M Nowicki; D Ostalska-Nowicka; M Kaczmarek; B Miskowiak; M Witt
Journal:  Histopathology       Date:  2007-02       Impact factor: 5.087

2.  Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia.

Authors:  Antonella N Witmer; Jiapei Dai; Herbert A Weich; Gijs F J M Vrensen; Reinier O Schlingemann
Journal:  J Histochem Cytochem       Date:  2002-06       Impact factor: 2.479

3.  Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma.

Authors:  Julian E Donckier; Luc Michel; Monique Delos; Xavier Havaux; Ronald Van Beneden
Journal:  Clin Endocrinol (Oxf)       Date:  2006-06       Impact factor: 3.478

4.  Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.

Authors:  Stefano La Rosa; Silvia Uccella; Giovanna Finzi; Luca Albarello; Fausto Sessa; Carlo Capella
Journal:  Hum Pathol       Date:  2003-01       Impact factor: 3.466

5.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer.

Authors:  Ines Gockel; Markus Moehler; Kirsten Frerichs; Daniel Drescher; Tran Tong Trinh; Friedrich Duenschede; Thomas Borschitz; Katrin Schimanski; Stefan Biesterfeld; Kerstin Herzer; Peter R Galle; Hauke Lang; Theodor Junginger; Carl C Schimanski
Journal:  Oncol Rep       Date:  2008-10       Impact factor: 3.906

7.  The KDR gene maps to human chromosome 4q31.2----q32, a locus which is distinct from locations for other type III growth factor receptor tyrosine kinases.

Authors:  B I Terman; S Jani-Sait; M E Carrion; T B Shows
Journal:  Cytogenet Cell Genet       Date:  1992

8.  Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.

Authors:  Koichi Nakamura; Yoh Zen; Yasunori Sato; Kazuto Kozaka; Osamu Matsui; Kenichi Harada; Yasuni Nakanuma
Journal:  Hum Pathol       Date:  2007-07-19       Impact factor: 3.466

9.  Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.

Authors:  Kousuke Yoshinaga; Kiyoshi Ito; Takuya Moriya; Satoru Nagase; Tadao Takano; Hitoshi Niikura; Nobuo Yaegashi; Yasufumi Sato
Journal:  Cancer Sci       Date:  2008-03-03       Impact factor: 6.716

10.  The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.

Authors:  A Kaipainen; J Korhonen; K Pajusola; O Aprelikova; M G Persico; B I Terman; K Alitalo
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  12 in total

1.  A murine-human chimeric IgG antibody against vascular endothelial growth factor receptor 2 inhibits angiogenesis in vitro.

Authors:  Guipeng Ding; Ximin Chen; Jin Zhu; Zhenqing Feng
Journal:  Cytotechnology       Date:  2013-07-24       Impact factor: 2.058

2.  FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT.

Authors:  Jian Feng; Xuesong Zhang; Huijun Zhu; Xudong Wang; Songshi Ni; Jianfei Huang
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

3.  Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer.

Authors:  Songshi Ni; Liqin Xu; Jianfei Huang; Jian Feng; Huijun Zhu; Gui Wang; Xudong Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

4.  Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer.

Authors:  Shu-Hui Liang; Xi-Zhang Yan; Biao-Luo Wang; Hai-Feng Jin; Li-Ping Yao; Ya-Ni Li; Min Chen; Yong-Zhan Nie; Xin Wang; Xue-Gang Guo; Kai-Chun Wu; Jie Ding; Dai-Ming Fan
Journal:  Tumour Biol       Date:  2013-04-23

5.  Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma.

Authors:  Wei Li; Hong-Xin Cai; Xu-Ming Ge; Kai Li; Wei-Dong Xu; Wei-Hong Shi
Journal:  Tumour Biol       Date:  2012-11-23

6.  An investigation of the resolution of inflammation (catabasis) in COPD.

Authors:  Aina Noguera; Cristina Gomez; Rosa Faner; Borja Cosio; Ana González-Périz; Joan Clària; Angel Carvajal; Alvar Agustí
Journal:  Respir Res       Date:  2012-11-13

7.  Molecularly Targeted Therapy of Human Hepatocellular Carcinoma Xenografts with Radio-iodinated Anti-VEGFR2 Murine-Human Chimeric Fab.

Authors:  Jianfei Huang; Qi Tang; Changjun Wang; Huixin Yu; Zhenqing Feng; Jin Zhu
Journal:  Sci Rep       Date:  2015-05-29       Impact factor: 4.379

8.  Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.

Authors:  Jian Feng; Liqin Xu; Songshi Ni; Jun Gu; Huijun Zhu; Haiying Wang; Shu Zhang; Wei Zhang; Jianfei Huang
Journal:  Oncotarget       Date:  2014-10-30

9.  Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients.

Authors:  Can Liu; Nan Zhou; Jieying Li; Jun Kong; Xi Guan; Xudong Wang
Journal:  Dis Markers       Date:  2017-06-08       Impact factor: 3.434

10.  AXL Is a Potential Target for the Treatment of Intestinal Fibrosis.

Authors:  Calen A Steiner; Eva S Rodansky; Laura A Johnson; Jeffrey A Berinstein; Kelly C Cushing; Sha Huang; Jason R Spence; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2021-02-16       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.